GGrantIndex
← Search

Rapid point of Care Diagnostics to Determine Cytomegalovirus Infection

$222,693N43FY2017AINIH

Zymeron Corporation, Durham NC

Investigators

Abstract

To develop a point-of-care test to measure the IgG and IgM antibodies from human blood and to determine the serostatus of CMV infection.

View original record on NIH RePORTER →